The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...

Embecta Corp (EMBC) reports a mixed quarter with revenue declines but strong growth in safety products and contract manufacturing, while focusing on debt reduction and strategic partnerships.

Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...

Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...

Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...

I was born missing an ear. What followed was years of well-intentioned violence from a medical system bent on solving the ...

Reported at 4:49 p.m. Saturday that an identity theft had occurred. 2000 block of Jaden Lane: Reported at 4:51 p.m. Saturday ...

Public officials and medical personnel in Davis County have a lot of confusing or inaccurate suggestions about how to legally ...

Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 ...